Skip to main content
31 Aug | 2023

Early action to control cardiovascular risk factors preserves brain metabolism

A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over five years.

26 Jul | 2023

The BBRC participates in a study to facilitate early diagnosis of Alzheimer's with a blood test

The research center of the Pasqual Maragall Foundation has made the first visit of the EAPP study in July 2023.

19 Jul | 2023

Presented at AAIC the results of a new drug that would slow cognitive decline

According to the data presented, and simultaneously published in JAMA, the treatment with donanemab will significantly reduce the levels of amyloid plaque.

19 Jul | 2023

Spain is among the top 10 countries in the world in Alzheimer's research

Among the most prominent research centers in Spain is the Barcelonaβeta Brain Research Center (BBRC) of the Pasqual Maragall Foundation.

13 Jul | 2023

The BBRC participates in AAIC 2023 with eight talks and thirty posters

During the meeting, the teams will disseminate their research findings to the international scientific community.

07 Jul | 2023

The United States approves the commercialisation of lecanemab, a drug that could slow the progression of Alzheimer’s

In order to know the situation of the drug in Europe, it will be necessary to wait for the resolution of the European Medicines Agency.

05 Jul | 2023

"More resources for better research": the 2022 Report of the Pasqual Maragall Foundation and the BBRC is now available

The document collects the most outstanding annual information on the scientific, social and economic activity of the two entities.

03 Jul | 2023

Barcelona hosts for the first time a specialised course on brain organoids

The program includes a day at the BBRC facilities, in which attendees will carry out a practical session on protein detection in organoid tissue.

19 Jun | 2023

European project PROMINENT will enhance diagnosis and treatment of neurodegenerative diseases

The Barcelonaβeta Brain Research Center will contribute to the development and validation of prediction models and diagnostic algorithms for the digital platform.